-
Signature
-
/s/ Michael J. Farrell, Chairman and CEO
-
Issuer symbol
-
RMD
-
Transactions as of
-
08 Dec 2025
-
Transactions value $
-
-$524,413
-
Form type
-
4
-
Filing time
-
09 Dec 2025, 15:17:15
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Farrell Michael J. |
Chairman and CEO, Director |
RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO |
/s/ Michael J. Farrell, Chairman and CEO |
09 Dec 2025 |
0001485164 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$730K |
+4.99K |
+1.07% |
$146.34 |
471K |
08 Dec 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$1.25M |
-4.99K |
-1.06% |
$251.41 |
466K |
08 Dec 2025 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
2.09K |
08 Dec 2025 |
Lisette and Michael Farrell Family Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-4.99K |
-8.33% |
$0.00 |
54.9K |
08 Dec 2025 |
ResMed Common Stock |
4.99K |
$146.34 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: